Composite setup radar
20
Risk-first tape
HKG Equity Snapshot
2696 Weekly Equity Report
Shanghai Henlius Biotech, Inc.
Latest Close
62.60 HKD
12 Jun 2026
1W Return
4.0%
latest completed week
4W Return
-7.3%
short-term follow-through
12W Return
-2.4%
quarterly tape
Trend Breadth
63.5%
33 of 52 weeks active
Volume Ratio
0.9x
vs 13-week average
Company Brief
What the company does
Shanghai Henlius Biotech, Inc. engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases. It offers HANLIKANG, a rituximab injection for treating active glomerulonephritis; HANQUYOU, a trastuzumab injection to treat breast and metastatic breast, and gastric cancer; HANDAYUAN, an adalimumab injection for the treatment of rheumatoid arthritis, ankylosing spondylitis, psoriasis, uveitis, polyarticular juvenile idiopathic arthritis, pediatric plaque psoriasis, Crohn's disease, and pediatric Crohn's disease; and HANBEITAI, a bevacizumab injection to treat metastatic colorectal cancer (mCRC) and recurrent non-small cell lung cancer. The company also develops HANSIZHUANG, …
Snapshot
What the weekly tape is saying
2696 closed the latest completed week at 62.60 HKD. The 4-week return is -7.3% and the 12-week return is -2.4%. Trend Signal is inactive, Market Dynamics is -0.71. Setup signature: Risk-first tape with a 20/100 composite read.
Trend Signal
Inactive
Market Dynamics
No fresh buy
Price vs Trend
-8.3%
Volume
0.9x
Setup Cockpit
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
Trend
35
Persistence of active Trend Signal over the last year and current streak.
Momentum
31
Blend of 4-week and 12-week follow-through.
Dynamics
17
Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength
0
Relative leadership and short-term RS change.
Volume
38
Participation compared with the 13-week volume baseline.
Risk Control
2
Drawdown and recent weekly volatility pressure.
16-week signal tape
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
Weekly return bar
Trend Signal dot
Positive Market Dynamics dot
Price Action
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price
Trend Line
Fair Value
Price map
- Trend Line
- 68.27 HKD
- Vs Trend Line
- -8.3%
- Fair Value
- 36.14 HKD
- Vs Fair Value
- 73.2%
- 52W High
- 92.00 HKD
- 52W Low
- 46.05 HKD
- Drawdown
- -32.0%
- Range Position
- 36.0%
Momentum
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 33
- 52W Active Breadth
- 63.5%
- Sector Scope
- HK Healthcare
- Sector Rank
- 34 of 257
- Sector Percentile
- 87.1%
Peer Context
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- 30 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 15 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Market Dynamics
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Market Dynamics
Relative Strength
Signal state
- Market Dynamics
- -0.71
- 4W MD Change
- -254.9%
- Relative Strength
- -4.88
- 4W RS Change
- -1156.1%
- Expectation
- Positive
- Probability
- 57.48%
Volume
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 4.1M
- 13W Average
- 4.5M
- 52W Average
- 5.5M
- Vs 13W
- 0.9x
- Vs 52W
- 0.7x
Risk Anatomy
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.0%
- 52W Volatility
- 7.4%
- Upside Weeks
- 25
- Downside Weeks
- 27
- Downside Breadth
- 51.9%
- Avg Gain / Loss
- 7.0% / -5.0%
Context
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 34.4B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 62.60 HKD | 4.0% | 68.27 HKD | 36.14 HKD | -0.71 | -4.88 | 4.1M | Off |
| 5 Jun 2026 | 60.20 HKD | -12.1% | 68.42 HKD | 35.81 HKD | -0.57 | -9.07 | 5.7M | Off |
| 29 May 2026 | 68.50 HKD | -3.2% | 68.45 HKD | 35.50 HKD | -0.22 | 2.93 | 4.7M | On |
| 22 May 2026 | 70.75 HKD | 4.8% | 68.50 HKD | 35.13 HKD | 0.08 | 5.10 | 2.9M | On |
| 15 May 2026 | 67.50 HKD | -8.2% | 68.45 HKD | 34.75 HKD | 0.46 | -0.39 | 3.6M | On |
| 8 May 2026 | 73.55 HKD | -2.2% | 68.59 HKD | 34.39 HKD | 0.89 | 7.48 | 3.6M | On |
| 1 May 2026 | 75.20 HKD | -9.1% | 68.53 HKD | 34.01 HKD | 1.10 | 13.57 | 2.4M | On |
| 24 Apr 2026 | 82.75 HKD | -2.0% | 68.47 HKD | 33.61 HKD | 1.27 | 25.06 | 3.9M | On |
| 17 Apr 2026 | 84.45 HKD | 1.3% | 68.10 HKD | 33.17 HKD | 1.17 | 28.16 | 4.8M | On |
| 10 Apr 2026 | 83.35 HKD | 8.8% | 67.87 HKD | 32.73 HKD | 0.83 | 29.41 | 5.9M | Off |
| 3 Apr 2026 | 76.60 HKD | 6.8% | 67.74 HKD | 32.28 HKD | 0.53 | 24.39 | 9.3M | Off |
| 27 Mar 2026 | 71.70 HKD | 11.8% | 67.92 HKD | 31.87 HKD | 0.28 | 18.70 | 4.7M | Off |
| 20 Mar 2026 | 64.15 HKD | -3.8% | 68.12 HKD | 31.48 HKD | 0.15 | 6.00 | 2.6M | Off |
| 13 Mar 2026 | 66.70 HKD | -3.3% | 68.77 HKD | 31.15 HKD | 0.22 | 10.51 | 3.8M | Off |